AAC
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Other Versions of this Article:
AAC.00146-08v1
52/9/3180    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Google Scholar
Right arrow Articles by Labbé, A.-C.
Right arrow Articles by Pépin, J.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Labbé, A.-C.
Right arrow Articles by Pépin, J.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, September 2008, p. 3180-3187, Vol. 52, No. 9
0066-4804/08/$08.00+0     doi:10.1128/AAC.00146-08
Copyright © 2008, American Society for Microbiology. All Rights Reserved.

Clostridium difficile Infections in a Canadian Tertiary Care Hospital before and during a Regional Epidemic Associated with the BI/NAP1/027 Strain{triangledown}

Annie-Claude Labbé,1,2* Louise Poirier,1,2 Duncan MacCannell,3 Thomas Louie,3 Michel Savoie,4 Claire Béliveau,1,2 Michel Laverdière,1,2 and Jacques Pépin5

Department of Microbiology, Hôpital Maisonneuve-Rosemont, Montréal, Québec, Canada,1 Department of Microbiology and Immunology, University of Montreal, Québec, Canada,2 Department of Microbiology and Infectious Diseases, University of Calgary, Calgary, Alberta, Canada,3 Department of Pharmacy, Hôpital Maisonneuve-Rosemont, Montréal, Québec, Canada,4 University of Sherbrooke, Sherbrooke, Québec, Canada5

Received 2 February 2008/ Returned for modification 30 March 2008/ Accepted 15 June 2008

Since 2002, an epidemic of Clostridium difficile infections has occurred in southern Quebec, Canada. At Hôpital Maisonneuve-Rosemont, Montreal, Quebec, Canada, the incidence of C. difficile infections increased from 11/1,000 admissions (1999 to 2002) to 27/1,000 admissions (2003 to 2005). We compared the exposures and outcomes for patients infected with strains with different ribopatterns isolated before (n = 55) and during (n = 175) the epidemic, as well as the in vitro activities of antibiotics against those isolates. During the preepidemic period, 46 isolates (84%) were of ribotype 001, 1 was of ribotype 027, and 8 were of other ribopattern types. During the epidemic period, ribotype 027 strains accounted for 140 (80%) isolates; 26 (15%) were of ribotype 001, and 7 were of other ribopattern types. Ribotype 027 strains were highly resistant to fluoroquinolones (FQs) but were susceptible to clindamycin. A pattern of prior specific antibiotic exposure that selected for antibiotic-resistant ribotype C. difficile infections was observed for FQs (ribotype 027) and clindamycin (ribotype 001). The rate of mortality was higher among older patients, those with a high Charlson comorbidity index, and those with longer previous hospitalizations. By multivariate analysis, patients infected with ribotype 027 were twice as likely to die within 30 days of diagnosis than patients infected with other ribotypes (adjusted odds ratio, 2.06; 95% confidence interval, 1.00 to 4.22). The observations from this study support the notion that continued selective antibiotic pressure resulted in the superimposition of the hypertoxigenic ribotype 027 clone on top of the prior dominant ribotype 001 clone in a setting of preexisting high endemicity, thus leading to the high rates of morbidity and mortality seen in the Quebec outbreak. Stringent antibiotic stewardship measures, combined with aggressive infection control, are required to curtail the epidemic of C. difficile infections.


* Corresponding author. Mailing address: Department of Microbiology, Hôpital Maisonneuve-Rosemont, 5415 Boul. Assomption, Montréal, Québec, Canada, H1T 2M4. Phone: (514) 252-3400, ext. 4524. Fax: (514) 252-3898. E-mail: ac.labbe{at}umontreal.ca

{triangledown} Published ahead of print on 23 June 2008.


Antimicrobial Agents and Chemotherapy, September 2008, p. 3180-3187, Vol. 52, No. 9
0066-4804/08/$08.00+0     doi:10.1128/AAC.00146-08
Copyright © 2008, American Society for Microbiology. All Rights Reserved.







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Clin. Vaccine Immunol. Clin. Microbiol. Rev.
J. Clin. Microbiol. ALL ASM JOURNALS

Copyright © 2008 by the American Society for Microbiology. All rights reserved.